Association of ANGPTL3, ANGPTL4, and DOCK7 polymorphisms with lipid traits and long-term clinical outcomes in patients undergoing PCI
Despite advances in PCI and lipid-lowering therapy, substantial residual cardiovascular risk persists in coronary artery disease (CAD) patients even after achieving LDL-C targets. Remnant cholesterol (RC) from triglyceride-rich lipoproteins is an independent causal driver of this risk. ANGPTL3 and ANGPTL4 regulat...